Redeye is encouraged to learn that Devyser has been awarded a tender from Héma-Québec in Québec, Canada, for its non-invasive fetal RHD detection product. We believe that the deal validates the attractiveness of Devyser’s offering in national screening tenders and continue to see strong growth prospects for the company over the coming years.